CGEN · Compugen Ltd · Metrics
Market Cap
$223.34M
Shares
94.72M
Volume · Oct 5
176.06K
Avg daily vol (3M)
251.13K
CGEN metrics
48 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$2.31
Market cap
$223.34M
Price action
20 metricsPrice change (1W)
-2.9%
Price change (30D)
-10.8%
Price change (3M)
+1.3%
Price change (6M)
+2.2%
Price change (YTD)
+51.0%
Price change (1Y)
+31.3%
Trailing year
Price change (5Y)
-61.3%
52-week high
$3.10
52-week low
$1.47
Change from 52-week high
-25.5%
Change from 52-week low
+57.1%
Annualized volatility
68.9%
Annualized volatility (3M)
50.1%
Beta
1.7
RSI (14D)
40.4
Price vs SMA 50
-5.8%
Price vs SMA 200
+2.5%
Avg volume (3M)
251,134
Relative volume
0.5
Average dollar volume
$622,181
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
94.72M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
2.2
reciprocal yield 46.0%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-03
Profitability
9 metricsGross margin
87.3%
Operating margin
43.1%
Trailing 12 months
Net margin
48.6%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+161.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+4.8%
Year over year · more shares
Revenue CAGR (3Y)
+113.3%
Revenue CAGR (5Y)
+105.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
34.4%
Return on assets
22.6%
Debt / equity
—
Current ratio
6.6
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
6.6
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$90.60M
Total assets
$156.57M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
83
13F filer change QoQ
+4
Institutional ownership
15.2%
Short interest
3 metricsShort interest
2.5%
Latest settlement · 12.0 days to cover
Days to cover
12.0d
Short-squeeze score
57 / 100
Insider activity
2 metricsNet insider buying (90D)
−$4,688
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—